POST LEONARD E

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 9. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5 of 9
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
CG Oncology, Inc.—Option exercisenothing paid1,000 sharesSep 17, 2026CG Oncology, Inc.nothing paidExercise · Sep 17Option exercise1,000Sep 17, 2026
CG Oncology, Inc.—Open-market sell$72,9801,000 sharesSep 17, 2026CG Oncology, Inc.$72,980Sell · Sep 17Open-market sell1,000Sep 17, 2026
CG Oncology, Inc.—Option exercise$6001,000 sharesSep 17, 2026CG Oncology, Inc.$600Exercise · Sep 17Option exercise1,000Sep 17, 2026
CG Oncology, Inc.—Option exercisenothing paid1,000 sharesAug 18, 2026CG Oncology, Inc.nothing paidExercise · Aug 18Option exercise1,000Aug 18, 2026
CG Oncology, Inc.—Open-market sell$74,5401,000 sharesAug 18, 2026CG Oncology, Inc.$74,540Sell · Aug 18Open-market sell1,000Aug 18, 2026